Season 6: Episode Four. The ACLS Update You Didn't Know You Needed

What if the most important thing about the 2025 ACLS guidelines isn't what changed — but what the science is already outpacing? In this episode, Dr. Martin Bennett, Dr. Adam Brenner, and Dr. Scott Ekin walk through the latest American Heart Association updates and hold them up against what the evidence is actually telling us.Dr. Ekin breaks down the official changes — from the atropine dose that quietly doubled to the oxygen saturation target that finally got specific — while the delegates weigh in on where AHA is playing it safe. Double sequential defibrillation showed a 30% survival-to-discharge rate in its landmark trial, but the guidelines won't commit. Calcium for hyperkalemia? Three delegates and decades of clinical experience respectfully disagree with "insufficient evidence."Along the way, the conversation lands on what might matter most: the growing recognition that BLS owns the cardiac arrest. Early CPR and rapid defibrillation still move the survival needle more than any drug or advanced airway — and the delegates make the case that an i-gel and uninterrupted compressions beat a heroic intubation attempt every time. Dr. Brenner previews emerging research on CPR hand positioning that could change what we teach about compressions, and the group tackles the post-ROSC tightrope of blood pressure targets, ventilation goals, and why a second hypotensive episode can undo everything you just fought for.Join the Kitsap physician delegates for an episode that separates what's settled from what's evolving — and reminds us that in ACLS, the most dangerous thing isn't a wrong answer. It's an old one you never thought to question.